These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23442735)
1. Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Cooper CL; O'Toole SA; Kench JG Pathology; 2013 Apr; 45(3):286-304. PubMed ID: 23442735 [TBL] [Abstract][Full Text] [Related]
2. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Basturk O; Hong SM; Wood LD; Adsay NV; Albores-Saavedra J; Biankin AV; Brosens LA; Fukushima N; Goggins M; Hruban RH; Kato Y; Klimstra DS; Klöppel G; Krasinskas A; Longnecker DS; Matthaei H; Offerhaus GJ; Shimizu M; Takaori K; Terris B; Yachida S; Esposito I; Furukawa T; Am J Surg Pathol; 2015 Dec; 39(12):1730-41. PubMed ID: 26559377 [TBL] [Abstract][Full Text] [Related]
3. Neoplastic Progression in Macroscopic Precursor Lesions of the Pancreas. Thompson ED Arch Pathol Lab Med; 2024 Sep; 148(9):980-988. PubMed ID: 38386006 [TBL] [Abstract][Full Text] [Related]
4. Premalignant cystic neoplasms of the pancreas. Dudeja V; Allen PJ Semin Oncol; 2015 Feb; 42(1):70-85. PubMed ID: 25726053 [TBL] [Abstract][Full Text] [Related]
5. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Singh M; Maitra A Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961 [TBL] [Abstract][Full Text] [Related]
6. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas. Pittman ME; Rao R; Hruban RH Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063 [TBL] [Abstract][Full Text] [Related]
7. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889 [TBL] [Abstract][Full Text] [Related]
8. Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma? Chidambaram S; Kawka M; Gall TM; Cunningham D; Jiao LR Future Oncol; 2022 Jul; 18(23):2605-2612. PubMed ID: 35730473 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer? Haugk B Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068 [TBL] [Abstract][Full Text] [Related]
10. Identification and analysis of precursors to invasive pancreatic cancer. Matthaei H; Dal Molin M; Maitra A Methods Mol Biol; 2013; 980():1-12. PubMed ID: 23359146 [TBL] [Abstract][Full Text] [Related]
11. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. Fischer CG; Wood LD J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857 [TBL] [Abstract][Full Text] [Related]
12. Molecular biomarkers have the potential to improve the diagnostic work-up of pancreatic cystic lesions. Plougmann JI; Klausen P; Karstensen JG; Vilmann P; Hasselby JP; Hansen CP; Kalaitzakis E Scand J Gastroenterol; 2017 Sep; 52(9):932-940. PubMed ID: 28552018 [TBL] [Abstract][Full Text] [Related]
13. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma]. Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019 [TBL] [Abstract][Full Text] [Related]
14. Current understanding of precursors to pancreatic cancer. Takaori K J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms: the interest of endoscopic ultrasonography. Maire F; Couvelard A; Palazzo L; Aubert A; Vullierme MP; Rebours V; Hammel P; Sauvanet A; Levy P; Ruszniewski P Pancreas; 2013 Nov; 42(8):1262-6. PubMed ID: 24152960 [TBL] [Abstract][Full Text] [Related]
19. Mucin expression profile in pancreatic cancer and the precursor lesions. Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199 [TBL] [Abstract][Full Text] [Related]
20. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Brune K; Abe T; Canto M; O'Malley L; Klein AP; Maitra A; Volkan Adsay N; Fishman EK; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH Am J Surg Pathol; 2006 Sep; 30(9):1067-76. PubMed ID: 16931950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]